Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools GIST

GIST

Programs, trials, and reported response and survival for gastrointestinal stromal tumor.

Data as of 11.07.2026

All studies

Imatinib

S0033 (one of the dose trials)

Novartis · Phase 3 · Terminated · Enrollment 748

NCT00009906

ArmPopulationDoseEstimandComparatorEfficacy

No efficacy figure is in this file for this study.